Tasly Pharmaceutical Group Co Ltd (600535) — Cash Flow Quality Index
Tasly Pharmaceutical Group Co Ltd (600535) has a Cash Flow Quality Index of 4.56x as of December 2025. Operating cash flow of CN¥552.13 Million exceeds net income of CN¥121.03 Million, indicating high earnings quality where cash backs reported profits. Explore 600535 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tasly Pharmaceutical Group Co Ltd Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Tasly Pharmaceutical Group Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600535 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tasly Pharmaceutical Group Co Ltd (2001–2025)
Year-by-year earnings quality comparison for Tasly Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see Tasly Pharmaceutical Group Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.29x | CN¥1.42 Billion | CN¥1.11 Billion | ▼ -45.0% |
| 2024 | 2.35x | CN¥2.01 Billion | CN¥859.06 Million | ▼ -7.4% |
| 2023 | 2.53x | CN¥2.58 Billion | CN¥1.02 Billion | ▼ -91.4% |
| 2022 | 29.31x | CN¥2.29 Billion | CN¥77.97 Million | ▲ +2419.1% |
| 2021 | 1.16x | CN¥2.80 Billion | CN¥2.41 Billion | ▼ -26.9% |
| 2020 | 1.59x | CN¥1.79 Billion | CN¥1.13 Billion | ▼ -5.0% |
| 2019 | 1.67x | CN¥1.68 Billion | CN¥1.00 Billion | ▲ +78.5% |
| 2018 | 0.94x | CN¥1.49 Billion | CN¥1.59 Billion | ▲ +260.0% |
| 2017 | -0.59x | CN¥-822.56 Million | CN¥1.40 Billion | ▼ -162.0% |
| 2016 | 0.95x | CN¥1.15 Billion | CN¥1.22 Billion | ▲ +324.1% |
| 2015 | 0.22x | CN¥340.00 Million | CN¥1.52 Billion | ▼ -47.5% |
| 2014 | 0.43x | CN¥616.76 Million | CN¥1.45 Billion | ▲ +43.3% |
| 2013 | 0.30x | CN¥346.17 Million | CN¥1.17 Billion | ▼ -43.1% |
| 2012 | 0.52x | CN¥413.31 Million | CN¥792.08 Million | ▲ +147.1% |
| 2011 | 0.21x | CN¥135.14 Million | CN¥639.96 Million | ▼ -75.4% |
| 2010 | 0.86x | CN¥395.05 Million | CN¥459.43 Million | ▼ -30.5% |
| 2009 | 1.24x | CN¥400.39 Million | CN¥323.63 Million | ▲ +19.0% |
| 2008 | 1.04x | CN¥260.21 Million | CN¥250.38 Million | ▼ -23.6% |
| 2007 | 1.36x | CN¥221.55 Million | CN¥162.97 Million | ▲ +106.7% |
| 2006 | 0.66x | CN¥140.56 Million | CN¥213.70 Million | ▼ -40.4% |
| 2005 | 1.10x | CN¥214.90 Million | CN¥194.60 Million | ▼ -5.1% |
| 2004 | 1.16x | CN¥203.27 Million | CN¥174.63 Million | ▲ +180.6% |
| 2003 | 0.41x | CN¥59.00 Million | CN¥142.22 Million | ▼ -76.4% |
| 2002 | 1.76x | CN¥206.22 Million | CN¥117.27 Million | ▲ +116.8% |
| 2001 | 0.81x | CN¥83.77 Million | CN¥103.29 Million | — |